Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 10:03 am Sale | 2025-05-30 | 13G | AnaptysBio, Inc. ANAB | FMR LLC | 254,212 0.900% | -1,650,942 (-86.66%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,368,370 7.700% | 676,998 (+40.03%) | Filing History |
| 2025-05-12 11:11 am Purchase | 2025-03-31 | 13G | AnaptysBio, Inc. ANAB | GOLDMAN SACHS GROUP INC GS | 1,588,654 5.200% | 1,588,654 (New Position) | Filing History |
| 2025-05-12 10:24 am Sale | 2025-03-31 | 13G | AnaptysBio, Inc. ANAB | FMR LLC | 1,905,154 6.200% | -965,464 (-33.63%) | Filing History |
| 2025-04-30 10:57 am Purchase | 2025-03-31 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group | 1,517,325 4.940% | 137,210 (+9.94%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | AnaptysBio, Inc. ANAB | BlackRock Inc. BLK | 1,900,844 6.200% | -647,624 (-25.41%) | Filing History |
| 2025-03-07 4:42 pm Purchase | 2025-02-28 | 13G | AnaptysBio, Inc. ANAB | First Light Asset Management LLC | 4,653,068 15.170% | 4,653,068 (New Position) | Filing History |
| 2025-02-18 4:36 pm Purchase | 2025-02-14 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 1,691,372 5.600% | 902,827 (+114.49%) | Filing History |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 0 0.000% | -1,671,484 (Position Closed) | Filing History |
| 2025-02-14 11:27 am Sale | 2025-01-31 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund, L.P. | 463,241 1.500% | -1,192,054 (-72.01%) | Filing History |
| 2025-02-14 11:25 am Sale | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund, L.P. | 1,655,295 5.400% | -261,896 (-13.66%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | BlackRock Inc. BLK | 2,548,468 8.400% | 748,645 (+41.60%) | Filing History |
| 2024-12-18 4:30 pm Purchase | 2024-12-11 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 1,671,484 5.500% | 1,671,484 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL MANAGEMENT, LLC | 1,330,879 4.400% | 1,330,879 (New Position) | Filing History |
| 2024-11-14 09:24 am Sale | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 0 0.000% | -2,036,990 (Position Closed) | Filing History |
| 2024-08-16 12:07 pm Purchase | 2024-08-14 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,794,996 25.800% | 274,572 (+3.65%) | Filing History |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | AnaptysBio, Inc. ANAB | FMR LLC | 2,870,618 10.507% | 2,692,879 (+1515.07%) | Filing History |
| 2024-05-06 12:59 pm Purchase | 2024-04-29 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund, L.P. | 1,917,191 7.000% | 1,917,191 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL PARTNERS LP | 1,950,609 7.300% | -678,069 (-25.80%) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655 (-62.88%) | Filing History |